778-Som-Lalit Institute Of Business Management - Gujarat ...
778-Som-Lalit Institute Of Business Management - Gujarat ... 778-Som-Lalit Institute Of Business Management - Gujarat ...
-Duty-free imports which is allowed by the law are raw and half manufactured materials needed for industrial projects which are not available in the market Indian Pharma Industry Indian pharmaceutical industry is third largest in term of volume and stands 14 th in term of value in world. The total turnover of indian pharma industry between 2008 and September 2009 was us $21.04 billion according to department of pharmaceuticals ministry of chemicals and fertilizers. Thus the local market was worth us$12.26 billion. Sales relating all types of medicines in the country is hoped to reach around us$19.22 billion by 2012. There was many encouragement for growth in pharmaceutical industry by the government. The government started to encourage the growth of drug manufacturing by Indian companies in the early 1960s and the patents act in 1970. it was just because of liberation by Narashima Rao and finance minister Mamohan Shigh. There was growth possible. there were these main factor thus improment of drugs and growth in Pharma companies possible. The lack of heredity prescription made the nation market undesirable to the multinational companies that had dominated the market, while they streamed out. Indian companies carved a niche in both nation and world markets with expertise in reverse engineering new process of manufacturing drugs at low costs. all are looking for innovation in drugs. Although some of the larger companies have taken small step towards drug innovation. According to information, exports of pharmaceuticals products increased from us$6.23 billion in 2006-07 to us$8.7 billion in 2008-09 and both combined growth was 21.25% annually. There is expert research that India joined among the league of top 10 global pharmaceutical markets in term of sales by 2020 with value reaching us$50billion according to price water house coopers. There are major pharmaceutical firms like cadila healthcare, Ranbaxy cipla sun and piramal healthcare. 10 | P a g e
Pharmaceutical industry today The Indian pharmaceutical companies‘ number is fairly low. There is cheap labour in production for that reason there is foreign companies subsidiaries in India. In 2002, there was over 20,000 registered drug manufacturers in India sold $9 billion worth of bulk drugs. it was 85% of these formulations sold in India while over 60% of the bulk drugs exported, more to the United States and Russia. As studied, Mostly the players in the market are small-to-medium enterprises and 250 of the largest companies control 70% of the Indian market. Multinationals represent only 35% of the market, down from 70% thirty years ago according to act 1970. Challenges There are many challenges in India for pharmaceutical industry. Each company has to spend 5-10% of its revenue in r&d department. There are market leaders such as Ranbaxy and dr. reddy‘s laboratories spent only 5-10% of their revenues on r&d and western pharmaceutical like Pfizer whose research budget last year was greater than the combined revenues of Indian pharmaceutical industry. There is much other reason for difference in product. One is disparity in cost differential. Therefore advances in genomics have made research equipment more expensive than ever. Second, the drug discovery process is over involved by a dearth of qualified molecular biologists. Third, Pharma in India lack the academic collaboration that is crucial to drug development in the west and so far due to the disconnect between curriculum and industry. Pharmaceutical marketing called medico marketing or pharma marketing in some countries is the business of advertising or otherwise promoting the sale of pharmaceuticals or drugs. There is negative effect of marketing practices. Some evidence for marketing practices can negatively affect both patients and the health care profession. there is limit to advertising by pharmaceutical companies in many country. Economics Pharmaceutical company spending on marketing far exceeds that spent on research. there are some studies. there was $1.7 billion was spent in 2004 to market drugs to physicians in Canada and $21 billion spent in 2002. in 2005 pharma company has 11 | P a g e
- Page 1 and 2: A GLOBAL COUNTRY REPORT ON QATAR Su
- Page 3 and 4: ACKNOWLEDGEMENT We take this opport
- Page 5 and 6: Qatar pharmaceutical industry :Qata
- Page 7 and 8: stand for around two-thirds of the
- Page 9: these factors are playing in our ad
- Page 13 and 14: According to recent reports in The
- Page 15 and 16: • They also signed Arab concord p
- Page 17 and 18: • There is low investment in inno
- Page 19 and 20: • The increase of innovative cons
- Page 21 and 22: Threats: 1) Threat from low cost co
- Page 23 and 24: As long as the municipality‘s sup
- Page 25 and 26: Feasibility Study on the alternativ
- Page 27 and 28: The Museum of Islamic Arts, which c
- Page 29 and 30: famous as the Dawlat Qaṭar, is an
- Page 31 and 32: executes needs for new business opp
- Page 33 and 34: Energy Profile Qatar Before the eme
- Page 35 and 36: investment from Qatar in crude stor
- Page 37 and 38: • Ministry of Power and Central E
- Page 39 and 40: According to Crisil report (June 20
- Page 41 and 42: Developments in Transmission Power
- Page 43 and 44: companies. Several companies have a
- Page 45 and 46: for IPPs (which are feasible for co
- Page 47 and 48: EMERGENCY SERVICES The ambulance se
- Page 49 and 50: MEDICAL R&D IN QATAR Currently, the
- Page 51 and 52: Legal The main government hospitals
- Page 53 and 54: MEDICAL TRAVEL Medical tourism, tre
- Page 55 and 56: CHCs are run by community based org
- Page 57 and 58: 5) Restaurant business in Qatar Cur
- Page 59 and 60: Doing Business in Qatar In keeping
-Duty-free imports which is allowed by the law are raw and half manufactured<br />
materials needed for industrial projects which are not available in the market<br />
Indian Pharma Industry<br />
Indian pharmaceutical industry is third largest in term of volume and stands 14 th in<br />
term of value in world. The total turnover of indian pharma industry between 2008<br />
and September 2009 was us $21.04 billion according to department of<br />
pharmaceuticals ministry of chemicals and fertilizers. Thus the local market was<br />
worth us$12.26 billion. Sales relating all types of medicines in the country is hoped to<br />
reach around us$19.22 billion by 2012.<br />
There was many encouragement for growth in pharmaceutical industry by the<br />
government. The government started to encourage the growth of drug manufacturing<br />
by Indian companies in the early 1960s and the patents act in 1970. it was just<br />
because of liberation by Narashima Rao and finance minister Mamohan Shigh.<br />
There was growth possible. there were these main factor thus improment of drugs<br />
and growth in Pharma companies possible.<br />
The lack of heredity prescription made the nation market undesirable to the<br />
multinational companies that had dominated the market, while they streamed out.<br />
Indian companies carved a niche in both nation and world markets with expertise in<br />
reverse engineering new process of manufacturing drugs at low costs. all are looking<br />
for innovation in drugs. Although some of the larger companies have taken small<br />
step towards drug innovation.<br />
According to information, exports of pharmaceuticals products increased from<br />
us$6.23 billion in 2006-07 to us$8.7 billion in 2008-09 and both combined growth<br />
was 21.25% annually. There is expert research that India joined among the league of<br />
top 10 global pharmaceutical markets in term of sales by 2020 with value reaching<br />
us$50billion according to price water house coopers. There are major<br />
pharmaceutical firms like cadila healthcare, Ranbaxy cipla sun and piramal<br />
healthcare.<br />
10 | P a g e
Change language